Abstract: The present invention provides isolated monoclonal antibodies which bind to the MUC1 SEA domain. The invention also concerns the use of these antibodies in therapeutic and diagnostic methods.
Type:
Application
Filed:
March 11, 2021
Publication date:
March 16, 2023
Applicants:
BIOMODIFYING, LLC, Ramot at Tel-Aviv University Ltd.
Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
Type:
Grant
Filed:
November 16, 2011
Date of Patent:
February 11, 2014
Assignees:
Biomodifying, LLC, Ramot at Tel Aviv University Ltd.
Inventors:
Daniel B. Rubinstein, Daniel H. Wreschner
Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
Type:
Application
Filed:
November 16, 2011
Publication date:
August 16, 2012
Applicants:
BIOMODIFYING, LLC, RAMOT AT TEL AVIV UNIVERSITY, LTD.
Inventors:
DANIEL B. RUBINSTEIN, DANIEL H. WRESCHNER
Abstract: The present invention provides antibodies that simultaneously bind the ?- and ?-subunits of an intact MUC1 protein, and methods for making and using such antibodies.
Type:
Application
Filed:
January 27, 2006
Publication date:
September 18, 2008
Applicants:
Ramot At Tel Aviv University, Ltd., Biomodifying, LLC
Inventors:
Daniel B. Rubinstein, Daniel H. Wreschner